Delhi’s Drugs Control Department orders pharmacies to stop advertising medicine discounts that are considered misleading. The directive targets promotional claims implying discounts of up to 80%, directing retailers to halt such advertisements.
The department says genuine sales priced below the maximum retail price (MRP) are allowed, but discounts must be transparent, verifiable, and supported by proper records. Regulators also emphasize that marketing should not misrepresent pricing or the nature of the discount.
While the notice is administrative and focused on advertising practices, the stated distinction between permissible below-MRP sales and prohibited misleading promotion shapes how outlets describe the move. The reporting centers on the regulator’s compliance requirement for discount claims, rather than any specific pharmacy being named or immediate penalties being detailed in the available summaries.
